ReviewReviews in endocrine & metabolic disorders2025

Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions.

Rosaria M Ruggeri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.